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Abstract
Intracranial pressure (ICP) can be analyzed for its absolute value, usually in 
mmHg or cmH2O, its tendency over time and the waveform of its pulse. This 
chapter will focus on the waveform of the ICP pulse (ICPwf), already observed 
since 1881, and for a long time not understood. Studies conducted in recent decades 
show the correlation between the ICPwf and intracranial compliance (ICC), 
another important clinical parameter added to the practice in the second half of the 
last century. ICC allows physicians early analyzing patients’ neurological conditions 
related to disorders resulting from variations in cerebrospinal fluid (CSF), blood 
and intracranial tissue volumes. This chapter is an invitation to dive into the history 
and development of ICPwf analysis, clinical uses already adopted and others still 
under study.
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1. Introduction
Technological development has brought the opportunity for significant 
advances in the health area. As new sensors have been developed, tools for 
image acquisition and treatment are improved and analytical methods using 
modern algorithms and artificial intelligence are developing, the set of 
tools available to assist in the diagnosis and monitoring of patients has been 
expanded.
ICP is a good example of how technological advancement has led to clinical 
understanding. Initially, only the number corresponding to the mean ICP was 
used to guide clinical procedures. Until then, there was only one number, and the 
information was punctual, it was as if we looked at a photo.
Advancing in understanding disclosed the value of having available real time 
information on early stages of intracranial hypertension (ICH), thus, techniques 
that show the pressure trend curve proved to be remarkable for the follow-up of 
critically ill patients.
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The information resulting from morphology will be treated in greater detail in 
this chapter, and today it is known that monitoring ICP is far over knowledge of a 
mean value, but also its trend over time, and the morphology of the pressure pulse 
recognition.
2. History
The history of ICPwf is centuries-old. For understanding, it is necessary to go 
back to the year 1783, after researcher Alexander Monro [1], who started studies 
of intracranial structures. His work was later completed by George Kellie [2], 
giving rise to the Monro-Kellie doctrine. This doctrine showed that the volume of 
intracranial components (blood, CSF and brain tissue) and the bone box that con-
tains them is fixed. The volume of these components needs to be under balance, 
if there is an increase in one, the others need to compensate by reducing their 
volumes. Thus, intracranial hypertension (ICH) emerges when this compensation 
ceases to happen [3]. The stiffness of the skull was later challenged by the work of 
Sérgio Mascarenhas in 2012 [4].
Angelo Mosso, at the end of the 19th century, presented results showing the 
influence of brain activity on its blood flow. For the first time, it was possible to 
observe the brain pulses, through a system that captured these pulses and recorded 
them on paper. These figures can be seen in Zago’s manuscript [5]. Many years later 
these pulses were related to ICP and CSF [6].
Langfitt [7] brought an important contribution showing the mathematical 
hypothesis for the relationship between ICP and intracranial volume, making 
it easier to understand the importance of intracranial compliance (ICC=𝚫V/
𝚫P) in critical care. Marmarou [8] in 1975 added to the pressure-volume curve 
the information about the increase in the amplitude of ICPwf as the mean value 
of ICP increases, and demonstrated that ICPwf contains unique information on 
intracranial contents, this data has already proven useful in several diseases such 
as stroke, hydrocephalus, idiopathic intracranial hypertension and brain injuries. 
It is important for gathering information on cerebrovascular hemodynamics and 
also of the cerebrospinal compensatory system. In 1983, Cardoso [9] showed that 
with the increase in ICP, in addition to the increase in the amplitude of its pulse, 
there was also a change in its configuration, as morphology became pyramidal with 
an increase in amplitude in the middle region of the pulse. Cardoso also shows the 
ICPwf configuration: P1 - systolic peak, P2 - tidal wave and P3 - venous return 
(explained in detail below).
Hu [10], understanding the possibility of using ICPwf as information to aid in 
diagnosis, created an algorithm called MOCAIP (Morphological Clustering and 
Analysis of Continuous Intracranial Pressure). This software is able to turn the 
waveform into numbers to facilitate the interpretation of the medical team. Nucci 
[11], in 2016, presented results of a software to calculate ICPwf parameters and 
clusters of waveforms for different stages of pathology.
Ballestero [12] and Bollela [13], in 2017, presented studies with hydrocephalus 
and meningitis respectively, that showed the applicability of a new noninvasive 
sensor to monitor the ICPwf, in the Ballestero study the ICPwf was analyzed 
through the relationship between the amplitude of the P2 and P1 pulses.
ICPwf is an important information, increasingly disseminated among physicians. 
New methods and analyses facilitate the use of this parameter, which is useful and 
disseminating over clinical institutions. The next chapters will provide more details 
and clinical applications of ICPwf.
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3. Intracranial pressure- waveform pathophysiology
3.1 Waveform components
ICP is determined by the intracranial components volumes, as the brain tissue, 
the vascular or cerebral blood flow (CBF) and cerebrospinal fluid (CSF) [14, 15], 
and relations between them in a semi-rigid skull box, the Monroe-Kellie doctrine. 
Each cardiac beat corresponds to an ICP waveform composed of three peaks; arterial 
pulsation- P1, cerebral venous flow, secondary to autoregulation-derived cyclic 
fluctuations of arterial blood volume, reflecting intracranial compliance- P2, and 
the aortic valve closure- P3 (Figure 1a).
These cardiac-derived pulsatile signals are overlapped in time domain with the 
respiratory cycle, with influence in the cerebral venous pulsation by means of intra-
thoracic pressure generated by breathing, disclosed as slow waves [16] (Figure 1b). 
Moreover, ventilation plays a direct and remarkable role over CBF [17]. Thus, ICP 
is influenced by many physiological factors from extra and intracranial compart-
ments. Moreover, factors as age, body posture, time of day as well as the clinical 
condition also are considerable variables, although in absence of disturbances, 
mean ICP is kept mostly within a range between 7 and 15 mmHg for adults, 3 and 
6 mmHg in children, and between 1.5 and 6 mmHg in term infants [18].
There is an existing volume of reserve in the brain which is around 60–80 mL 
in young persons and approximately 100–140 mL in geriatric population, because 
of ongoing cerebral atrophy with age. However, in normal conditions and for short 
time observations, the brain volume is typically static, with mean ICP varying 
mainly according to the CBF and the balance between production and absorption 
or outflow of the CSF. The relation observed between these intracranial compo-
nents is named intracranial compliance (ICC). Compensatory mechanisms exist 
to maintain intracranial volume homeostasis by extrusion of the CSF or venous 
blood, in order to preserve ICC, otherwise, these efforts may be insufficient in 
pathological conditions (i.e. traumatic brain injury) with intracranial hyperten-
sion (ICH) and ICC impairment producing primary or secondary brain tissue 
damage [19, 20].
Langfitt et al. characterized the transmission of pressure across the intracranial 
compartments as the intracranial elastance curve, observing an exponential behavior 
between ICP and intracranial volume [21], from a stable ICP vs. volume relation until 
Figure 1. 
(a) One single arterial pulse transmitted to the intracranial compartment, with three peaks observed; systolic 
peak (P1), tidal peak (P2) and aortic valve closure peak (P3). (b) Respiratory slow waves overlapping cardiac 
intracranial pulses spectrum (from Hall et al. [16]).
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when a change in volume of any component will result in a commensurate change in 
ICP (Figure 2a). When ICP raises and compromises ICC, an inversion in ICP peaks 
relations may be observed [9], with ICH transmitted to the venous and ventricular 
compartments, affecting the buffering mechanisms (Figure 2b).
When mean ICP is elevated, the vascular (cardiac) waveform amplitude 
increases while the respiratory waveform amplitude decreases, associated with 
changes in the relationship between peaks P1, P2, and P3 [19, 22]. Different waves 
morphologies could reflect the residual compensatory capacity of the brain, since 
changes in the ICP wave shape are informative on an incoming or established 
 alteration of the intracranial system (Figure 3) [11].
3.2 Slow waves
Additionally to all that was explained above, further phenomena in the observance 
of ICP waveforms may occur with high importance on alerting the neurophysician to 
initiate ICP control measures on an urgent basis. These phenomena were named slow 
waves by Lundberg et al., typically described as A, B and C waves (Figure 4). The A 
waves are denoted as plateau waves or vasogenic waves occurring during very high ICP 
(> 50 mmHg), the B waves are short-duration elevations in ICP (1 to 2 per minute) 
with variable pressure levels up to 30–50 mmHg. C waves are more frequent (about 4–8 
waves per minute) elevations of mean ICP (up to about 30 mmHg). A waves are clearly 
severe and with elevated risk of poor prognosis, whereas the clinical implication of the 
B waves is a research question that remains to be determined, since they are non-specific 
Figure 2. 
(a) Langfitt curve representing volume x ICP exponential behavior with A- normal ICC, B- intracranial 
buffering capacity begins to exhaust and C- ICC impaired with rapid ICP elevation (from Canac et al. [18]) 
(b) representation of altered ICP curve with ICC impairment.
Figure 3. 
A - Normal, if the first peak (P1) exceeds the other two; B - potentially pathological, if the tidal peak (P2) 
equals or slightly exceeds the systolic one (P1) and the dicrotic peak equals or is slightly inferior to P1; class 
C - likely pathological, if the tidal and the dicrotic peaks exceed the first one; D and E- pathological, if the 
tidal and the dicrotic peaks surmount the first one or if the shape of the curve is so rounded as not to permit the 
identification of the three peaks (from Nucci et al. [11]).
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Figure 4. 
Lundberg A, B and C waves (from Hirzallah et al. [24]).
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indicators of diminished compliance and can also be present in patients with normal 
ICP [23]. Finally, C waves are products of cardiac and respiratory cycles interactions.
4. Intracranial compliance in real world
The next paragraphs will provide information on how to incorporate waveform 
information of ICP into clinical daily life, adding this information to the clinical 
set and adjunct with other diagnostic methods in different pathologies. It is worth 
mentioning that this information has been shown to be useful in situations where 
subjects present suspicion, risk or diagnosis of changes in ICC.
4.1 Aneurysm
Non-traumatic subarachnoid hemorrhage (SAH) is a situation that often results 
from the rupture of an intracerebral aneurysm [25]. SAH is associated with high 
morbidity and mortality and requires a multidisciplinary treatment, because of its 
high risk of complications [26].
Upon recognition, improved outcomes are dependent upon treatment by 
qualified high-volume centers with adequate neurovascular teams. Expeditiously 
determining the precipitating factor and subsequent mitigation of the cause(s) 
are the initial primary focus. Treatment involves early securing of a ruptured 
aneurysm, whether a surgical procedure or endovascular. Prior to securing the 
aneurysm, securing the airway, maintaining proper circulation, treating hydro-
cephalus, and managing blood pressure remain top priorities. After intervention, 
ICU observation and routine exams are compulsory.
Once patients presenting with aneurysmal SAH are acutely stabilized, they are 
evaluated for pathology-specific complications such as development of hydrocepha-
lus and re-hemorrhage. Various grading scales are employed early in management to 
communicate the severity and prognosis of the pathology. Following stabilization and 
initial evaluation, patients should be transferred and admitted to intensive care units 
with a multidisciplinary team. Interim/short-term acute care strategies are employed 
to prevent rebleeding, assess hydrocephalus, maintain normotension, and reverse 
anticoagulant/antiplatelet agents. The risk of acute rebleed and long-term prevention 
of rebleed is not completely attenuated until aneurysm exclusion is performed.
Concurrent to the those risks above mentioned, in the extreme acute phase 
(first 48 hours) of SAH, the encephalic microvascular constriction promoted by 
hemoglobin degradation in the subarachnoid space may lead to a low cerebral blood 
flow (CBF) phenomena, with potential for brain swelling and ICC impairment. 
Techniques for monitoring ICC and CBF (such as transcranial Doppler) may play a 
crucial role in this phase.
Later, in the subsequent SAH phase, an inverse behavior is commonly seen in 
accordance with bleed severity, the so-called hyperemic phase. In this situation 
subjects present microvascular dilation, this time leading to ICC impairment for 
excess of CBF. An optimal therapy here is adapting CBF for satisfactory neuronal 
supply, under ICC adequate limits.
An additional threat for patients in this phase is the development of vasospasm, 
a complication which elevates risk of delayed cerebral ischemia, in opportunities 
needing endovascular management. The latter, associated with medical compli-
cations including fever, hyperglycemia, hyponatremia, cardiac and pulmonary 
complications, deep venous thrombosis and anemia may raise risk of ICC impair-
ment. While scores classifications exist to determine an admission grade in order 
to provide prognostic information, outcomes are influenced by many additional 
7
Intracranial Pressure Waveform: History, Fundamentals and Applications in Brain Injuries
DOI: http://dx.doi.org/10.5772/intechopen.94077
items, including a patient’s values and preferences, comorbidities, social support, 
resilience, and time for recovery [27–31].
4.2 Tumor
The incidence and survival of patients with neuro-oncologic conditions have 
been increasing. Both primary central nervous and other types of cancer patients 
live longer due to early diagnosis and better treatment options. Global Burden 
Disease Study in 2016, there were 330,000 incident cases of CNS cancer and 
227,000 deaths worldwide that year. It reflects the 17.3% increase in incidence 
between 1990 and 2016.
Extension of life expectancy and on the incidence of cancer itself predisposes 
to an increment in the occurrence of a variety of neurologic complications that can 
result in high morbidity and mortality [32, 33].
These conditions often result in hospital admissions, generally in an ICU bed, 
creating a heavy burden to the health care system since primary cancer patients’ 
treatment costs 20-times more than age-matched controls without cancer [33].
The complications could occur due to a direct result of the tumor itself, to an indi-
rect effect of cancer, or as a result of chemotherapy, radiotherapy, and other medical 
interventions. Recognizing the mechanism might help one early diagnosis and initi-
ate treatment. As a mass effect directly, or even a compromise of CSF transit because 
of ventricle compression, intracranial neoplasm may lead to ICC impairment.
4.3 Traumatic brain injury
The World Health Organization considers traumatic brain injury (TBI) an 
important global health priority as it is a critical public health problem involving 
young adults worldwide. The leading causes of TBI are road traffic collisions, falls 
and interpersonal violence. This injury not only causes a large number of deaths, 
impairments and disabilities for individuals and their families, but also incurs great 
economic cost to healthcare systems due to required long-term care, rehabilitation, 
and loss of productivity [34].
TBI can be classified by clinical severity (mild, moderate, or severe) according 
to the Glasgow Coma Scale (GCS); pathoanatomic type (focal or diffuse) according 
to the extent of damaged area; and mechanism of injury (penetrating or blunt) 
according to the kinematics (Table 1) [35–38].
The TBI-related cellular injury involves two different processes. The primary damage 
occurs on the moment of trauma, immediately by the direct impact and/or structural 
lesion. It includes vascular and tissue tearing that causes various types of hemorrhage 
and nerve fibers disruption (axotomy). The secondary damage involves cellular reactive 
processes such as inflammation and biochemical cascades that gradually develop over 
the course of hours, days, even weeks after the trauma. It causes metabolic changes 
potentially leading to brain swelling or hydrocephalus but can also be caused by low 
blood pressure, hypoxia, seizures, or central nervous system infection [37, 38].
Both processes are intertwined and can contribute to complications, for instance, 
hemorrhagic progression of a contusion, a breakdown in the blood–brain barrier 
(BBB), and increased intracranial pressure (ICP). The expansion of an intracranial 
bleeding not only alters the dynamic shared space of encephalic parenchyma, 
vascular structures, and cerebral spinal fluid (CSF) inside cranial cavity – inferred 
intracranial compliance – but also triggers cytotoxic responses of brain cells. In 
addition, if there is a dysfunction of BBB its permeability changes letting plasma, 
proteins and proinflammatory mediators influx into the interstitial compartment 
causing edema, neurotransmitters imbalance, compressing all structures [38, 39].
Advancement and New Understanding in Brain Injury
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As a result of this intricate association the ICP may rise if intrinsic compensatory 
mechanisms are not preserved and the sustained hypertension can prevent adequate 
perfusion depriving the brain of oxygen and nutrition. The combination of all 
situations related to TBI mentioned above need specific and adequate management 
through the whole trauma assistance from the pre-hospital setting to the critical 
care unit (CCU) and subsequent rehabilitation [36, 40].
The main method of assessment and management of severe TBI is monitoring 
and treatment of ICP. It is a level II-B of evidence recommended to reduce in-
hospital and 2-week post-injury mortality [23, 41].
Neurocritical care specialists routinely base their clinical reasoning looking at 
the absolute value of ICP – measured in mmHg or cmH2O – combined with imaging 
exams – CT-scan or MRI. However, the numbers may not translate the entire com-
plexity of intracranial dynamic. It is suggested that the ICP waves and the study of its 
morphology could bring differential evidence of altered intracranial compliance and 
changes of pressure regimen [14, 23, 42, 43].
A qualitative analysis of the ICP waveform [44] described the relationship 
between amplitude of ICP pulse wave, values of ICP, values of cerebral perfusion 
pressure (CPP), and the outcome of severe head-injured patients. Intracranial 
hypertension was evidenced by absolute values of ICP and CT-scan parameters. 
In those with fatal outcomes there was an increase in the ICP waveform amplitude 
along with an increase of ICP value up to 25 mmHg, however, above this value the 
amplitude began to decrease. This breakpoint trend in the amplitude-value relation-
ship was not present in patients with good/moderate outcome. Thus, it is suggested 
that the physics involving ICP, CPP and parenchyma dynamics inside intracranial 
cavities was somehow translated into the waveforms, and its analysis and correla-
tions could be a useful additional tool for outcome prediction.
Another study [45] involving TBI patients described the ICP plateau waves 
characteristics using multimodal brain monitoring as well as calculated indices 
of brain compensatory reserve and cerebrovascular reactivity. Plateau waves are 
associated with working cerebrovascular reactivity and occur in situations of 
Classification Categories Examples
Clinical severity Mild GCS: 13–15
Moderate GCS: 9–12
Severe GCS ≤ 8






Diffuse (widespread area) Diffuse axonal injury
Concussion
Chronic traumatic encephalopathy
Mechanism of injury Penetrating Gunshot wound/projectile





Different classifications of TBI.
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decreased volume-pressure compensatory reserve such as TBI and many other brain 
pathologies. It consists of sudden increases in ICP to peaks of 40-100 mmHg that 
persists for 5–20 minutes [14, 45, 46]. The study observed plateau waves in 44% of 
the patients and that abrupt increase of ICP above 40 mmHg was associated with an 
increase in amplitude of ICP pulse waveform and also with important decrease in 
CPP, cerebral blood flow and oxygenation, despite stable cardiovascular variables 
of arterial blood pressure and heart rate (Figure 5) [45].
When analyzing ICP pulse waveform during plateau waves, a statistically sig-
nificant increase in amplitude and a change in its shape were noted. The ICP pulse 
components (P1 < P2 > P3) showed altered ICC [45] (Figure 6).
Although slight increases in ICP that last for short period are not usually 
associated with poor outcome, if plateau waves are sustained over 30 minutes it 
could have a negative impact on patient’s recovery as intracranial hypertension 
compromises cerebral perfusion and implicates neuronal deterioration [14, 23, 
42, 43, 46]. The analysis of ICP absolute values and waveform patterns over time 
could provide important information for early detection of ICH in TBI patients of 
the mentioned study [45].
The debate about how ICP waveform analysis could provide improved clinical 
benefit and a more actionable evidence to bedside addresses integrated metrics on 
brain’s intrinsic compensatory capacity (autoregulation) and oxygenation, besides 
computational analysis of multiple continuous streams of neuro-monitoring data 
and equipment development to easily display this information [14, 23, 42–46].
In this way, non-invasive techniques are coming forward to give quick ICP 
information to neurocritical care team, including transcranial Doppler, optic 
nerve sheath diameter, near-infrared spectroscopy, tympanic membrane displace-
ment, visual-evoked potentials, some other measurements of the optic nerve, 
Figure 5. 
Example of multimodal brain monitoring recording during plateau wave, extracted from Dias et al. [45].
Figure 6. 
Altered ICP pulse waveform indicating compromised intracranial compliance, extracted from Dias et al. [45].
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retina, and pupil, besides the routinely used imaging exams of CT-scan and MRI 
[23, 42, 43, 45]. There is also a new non-invasive method of ICP monitoring that 
provides morphological data of ICP waves and intracranial compliance, adding 
celerity to this multimodal scenario [47, 48].
It is well established that ICH is an important issue after TBI because of its 
relationship to overall outcomes and all guidelines recommend a comprehensive 
ICP assessment – either invasively or non-invasively. Information about absolute 
values and waveform characteristics of ICP may together contribute to direct 
optimal management of TBI and good patient care [23, 42, 43, 45, 47, 48].
4.4 Increased ICP outside ICU environment
The brain constitutes approximately 80% of intracranial volume, and blood 
and CSF each account for 10% [49–51]. The first compensatory mechanism for 
maintenance of normal ICP involves displacement and reduction of the CSF 
compartment, reduction of CBF, and lastly, displacement of cerebral parenchyma 
causing herniation. The slower the increment in ICP, the more useful this regulatory 
system. Therefore, rapidly growing masses like malignant gliomas have a higher risk 
of causing brain herniation than slow-growing tumors like meningiomas or nerve 
sheath tumors [52].
Transient elevation in ICP, generally from 50 to 100 mmHg and 5 to 20 minutes, 
leads to plateau wave phenomena. It can occur spontaneously or start after coughing, 
sneezing, or changes in position. This transient intracranial hypertension period 
may be accompanied also by transient headache, transient alteration of the level of 
consciousness and focal deficits [49, 50].
Obesity and its relation with sleep apnea obstructive syndrome may show ICC 
impairment due to overnight hypercarbia leading to cerebral vasodilation. Also, 
this population is likely to develop chronic idiopathic intracranial hypertension. 
Moreover, hydrocephalus patients of any etiology, migraineurs, progressive neuro-
logical focal and/or gait disorders, all these situations mentioned here for outpatients 
practice raise the yellow sign on the need for ICC evaluation.
5. Conclusions
Advances on cerebral hemodynamics and intracranial compliance under-
standing brought to light by recent researches have made monitoring of these 
properties an essential practice in critical care. Likewise, advances in technology 
may convert intracranial compliance in a new vital sign present in daily practice 
in a near future.
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